0001567619-20-014338.txt : 20200805 0001567619-20-014338.hdr.sgml : 20200805 20200805170226 ACCESSION NUMBER: 0001567619-20-014338 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200803 FILED AS OF DATE: 20200805 DATE AS OF CHANGE: 20200805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burnett Patrick CENTRAL INDEX KEY: 0001741987 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39186 FILM NUMBER: 201078431 MAIL ADDRESS: STREET 1: C/O VERRICA PHARMACEUTICALS INC. STREET 2: 10 NORTH HIGH STREET, SUITE 200 CITY: WEST CHESTER STATE: PA ZIP: 19380 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcutis Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001787306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812974255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2945 TOWNSGATE ROAD STREET 2: SUITE 110 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 BUSINESS PHONE: 805-418-5006 MAIL ADDRESS: STREET 1: 2945 TOWNSGATE ROAD STREET 2: SUITE 110 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 FORMER COMPANY: FORMER CONFORMED NAME: Arcutis, Inc. DATE OF NAME CHANGE: 20190905 4 1 doc1.xml FORM 4 X0306 4 2020-08-03 0 0001787306 Arcutis Biotherapeutics, Inc. ARQT 0001741987 Burnett Patrick C/O ARCUTIS BIOTHERAPEUTICS, INC. 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE CA 91361 0 1 0 0 See Remarks Common Stock 2020-08-03 4 A 0 33500 0 A 33500 D Stock Option (Right to Buy) 25.89 2020-08-03 4 A 0 320000 0.00 A 2030-08-03 Common Stock 320000 320000 D Grant of Restricted Stock Units ("RSU"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Includes 33,500 RSUs. The RSUs will begin vesting upon the achievement of the performance-based milestones. The option vests as to 1/4 of the total shares on August 1, 2021, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested on August 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Senior Vice President and Chief Medical Officer /s/ John W. Smither, as Attorney-in-Fact for Patrick Burnett 2020-08-05